Access Statistics for Amanda Megan Cole

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
"New Age" Decision Making in HTA: Is It Applicable in Asia? 0 0 0 14 0 4 5 63
A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications 0 0 0 2 1 2 6 29
An Analysis of NICE Technology Appraisal Decisions 'Recommended in Line with Clinical Practice' 0 0 1 11 0 0 3 65
Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK 0 1 2 3 0 3 11 17
Barriers to Uptake of Minimal Access Surgery in the United Kingdom 0 0 0 13 0 1 5 28
Data Governance Arrangements for Real-World Evidence 0 0 0 12 0 0 3 44
Data Governance Arrangements for Real-World Evidence: South Korea 1 3 5 19 3 6 32 97
Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices? 0 0 0 1 0 0 6 36
Documento de debate sobre la fijación de precios en función de la indicación (IBP) ¿Deben variar los precios de los medicamentos según la indicación? 0 0 4 7 0 0 7 22
Economics of Innovative Payment Models Compared with Single Pricing of Pharmaceuticals 0 0 1 68 0 1 4 79
How Can Health Technology Assessments in the Asia-Pacific Area Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes? 0 0 0 14 0 0 2 18
Improving Efficiency and Resource Allocation in Future Cancer Care 0 0 8 27 0 3 25 110
Indication-Based Pricing (IBP) Consultation Report 1 1 6 8 4 5 27 46
Indication-Based Pricing (IBP) Discussion Paper: Should drug prices differ by indication? 0 0 5 18 2 3 17 67
Legal Barriers to the Better Use of Health Data to Deliver Pharmaceutical Innovation 0 0 0 15 0 1 5 36
Making Outcome-Based Payment a Reality in the NHS 0 0 7 23 8 14 64 156
NICE 'Optimised' Decisions: What is the Recommended Level of Patient Access? 0 0 0 5 1 2 11 18
The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries 0 0 0 10 1 2 9 57
Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates 0 0 0 13 0 0 6 63
Total Working Papers 2 5 39 283 20 47 248 1,051


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact? 0 0 2 6 3 5 12 46
Are the UK Systems of Innovation and Evaluation of Medical Devices Compatible? The Role of NICE’s Medical Technologies Evaluation Programme (MTEP) 0 1 2 14 0 2 17 52
Outcome-Based Payment Schemes: What Outcomes Do Patients with Cancer Value? 0 0 0 0 0 0 1 4
Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment 0 0 0 1 0 0 3 18
Total Journal Articles 0 1 4 21 3 7 33 120


Statistics updated 2021-12-05